Sherlock Biosciences
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk
LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2.
Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests
The agreements will increase access to testing in Asia through United PPE and in the Middle East through Cooper International, the foundation said.
In Brief This Week: OpGen, Hologic, Exact Sciences, Thermo Fisher, and More
News items for the in vitro diagnostics industry for the week of Jan. 4, 2021.
COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020
The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress